Gianfranco Arroyo1,2,3, Silvia Rodriguez4, Andres G Lescano1,2,3, Karen A Alroy5, Javier A Bustos1,2,3,4, Saul Santivañez6, Isidro Gonzales4, Herbert Saavedra4, E Javier Pretell7, Armando E Gonzalez8, Robert H Gilman5, Victor C W Tsang9, Hector H Garcia1,2,3,4. 1. School of Public Health and Management, Universidad Peruana Cayetano Heredia, Lima, Peru. 2. Department of Microbiology, School of Sciences, Universidad Peruana Cayetano Heredia, Lima, Peru. 3. Center for Global Health-Tumbes, Universidad Peruana Cayetano Heredia, Lima, Peru. 4. Cysticercosis Unit, Instituto Nacional de Ciencias Neurológicas, Lima, Peru. 5. Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland. 6. Instituto Peruano de Parasitología Clínica y Experimental, Lima. 7. Department of Neurology, Hospital Alberto Sabogal, Callao. 8. School of Veterinary Medicine, Universidad Nacional Mayor de San Marcos, Lima, Peru. 9. Georgia State University, Atlanta.
Abstract
Background: The enzyme-linked immunoelectrotransfer blot (EITB) assay is the reference serological test for neurocysticercosis (NCC). A positive result on EITB does not always correlate with the presence of active infections in the central nervous system (CNS), and patients with a single viable brain cyst may be EITB negative. Nonetheless, EITB antibody banding patterns appears to be related with the expression of 3 protein families of Taenia solium, and in turn with the characteristics of NCC in the CNS (type, stage, and burden of viable cysts). Methods: We evaluated EITB antibody banding patterns and brain imaging findings of 548 NCC cases. Similar banding patterns were grouped into homogeneous classes using latent class analysis. The association between classes and brain imaging findings was assessed. Results: Four classes were identified. Class 1 (patients negative or only positive to the GP50 band, related to the protein family of the same name) was associated with nonviable or single viable parenchymal cysticerci; class 2 (patients positive to bands GP42-39 and GP24, related to the T24-42 protein family, with or without anti-GP50 antibodies) was associated with intraparenchymal viable and nonviable infections; classes 3 and 4 (positive to GP50, GP42-39, and GP24 but also responding to low molecular weight bands GP21, GP18, GP14, and GP13, related to the 8 kDa protein family) were associated with extraparenchymal and intraparenchymal multiple viable cysticerci. Conclusions: EITB antibody banding patterns correlate with brain imaging findings and complement imaging information for the diagnosis of NCC and for staging NCC patients.
Background: The enzyme-linked immunoelectrotransfer blot (EITB) assay is the reference serological test for neurocysticercosis (NCC). A positive result on EITB does not always correlate with the presence of active infections in the central nervous system (CNS), and patients with a single viable brain cyst may be EITB negative. Nonetheless, EITB antibody banding patterns appears to be related with the expression of 3 protein families of Taenia solium, and in turn with the characteristics of NCC in the CNS (type, stage, and burden of viable cysts). Methods: We evaluated EITB antibody banding patterns and brain imaging findings of 548 NCC cases. Similar banding patterns were grouped into homogeneous classes using latent class analysis. The association between classes and brain imaging findings was assessed. Results: Four classes were identified. Class 1 (patients negative or only positive to the GP50 band, related to the protein family of the same name) was associated with nonviable or single viable parenchymal cysticerci; class 2 (patients positive to bands GP42-39 and GP24, related to the T24-42 protein family, with or without anti-GP50 antibodies) was associated with intraparenchymal viable and nonviable infections; classes 3 and 4 (positive to GP50, GP42-39, and GP24 but also responding to low molecular weight bands GP21, GP18, GP14, and GP13, related to the 8 kDa protein family) were associated with extraparenchymal and intraparenchymal multiple viable cysticerci. Conclusions: EITB antibody banding patterns correlate with brain imaging findings and complement imaging information for the diagnosis of NCC and for staging NCC patients.
Authors: Kathy Hancock; Sowmya Pattabhi; Ryan M Greene; Melinda L Yushak; Fatima Williams; Azra Khan; Jeffrey W Priest; Min Z Levine; Victor C W Tsang Journal: Mol Biochem Parasitol Date: 2004-01 Impact factor: 1.759
Authors: Hector H Garcia; Silvia Rodriguez; Robert H Gilman; Armando E Gonzalez; Victor C W Tsang Journal: Trop Med Int Health Date: 2012-07-19 Impact factor: 2.622
Authors: Elizabeth Ferrer; Pedro Bonay; Mildred Foster-Cuevas; Luis Miguel González; Iris Dávila; María Milagros Cortéz; Leslie J S Harrison; R Michael E Parkhouse; Teresa Gárate Journal: Mol Biochem Parasitol Date: 2006-12-15 Impact factor: 1.759
Authors: O H Del Brutto; T E Nash; A C White; V Rajshekhar; P P Wilkins; G Singh; C M Vasquez; P Salgado; R H Gilman; H H Garcia Journal: J Neurol Sci Date: 2016-11-21 Impact factor: 3.181
Authors: Kathy Hancock; Azra Khan; Fatima B Williams; Melinda L Yushak; Sowmya Pattabhi; John Noh; Victor C W Tsang Journal: J Clin Microbiol Date: 2003-06 Impact factor: 5.948
Authors: Gianfranco Arroyo; Javier A Bustos; Andres G Lescano; Isidro Gonzales; Herbert Saavedra; E Javier Pretell; Yesenia Castillo; Erika Perez; Pierre Dorny; Robert H Gilman; Seth E O'Neal; Armando E Gonzalez; Hector H Garcia Journal: J Clin Microbiol Date: 2021-12-01 Impact factor: 11.677
Authors: Jesus Abanto; Daniel Blanco; Herbert Saavedra; Isidro Gonzales; Diego Siu; E Javier Pretell; Javier A Bustos; Hector H Garcia Journal: Am J Trop Med Hyg Date: 2021-07-07 Impact factor: 3.707
Authors: Jesica A Herrick; Javier A Bustos; Philip Clapham; Hector H Garcia; Jeffrey A Loeb Journal: Am J Trop Med Hyg Date: 2020-05-14 Impact factor: 2.345